Furthermore, we have established a potential CHD mechanism, whereby chamber and septal defects seen in patients carrying heterozygous NKX2-5 homeodomain mutations may in part be due to disrupted PPIs between NKX2-5 and RXRα. Here, NKX2-5 is linked to coronary artery disorder.